Skip to main content
Kathleen Burns, MD, Pathology, Boston, MA

Kathleen Helen Burns MD PhD

Hematopathology, Clinical Pathology


Professor of Pathology, Harvard Medical School; Chair of Pathology, Dana-Farber Cancer Institute

Join to view full profile
  • 450 Brookline AveBoston, MA 02215

Dr. Burns is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Kathleen Burns, M.D., Ph.D., joined Dana-Farber in 2020 as Chair of the Department of Pathology. She received her M.D. and Ph.D. degrees from Baylor College of Medicine, and was recruited to Johns Hopkins University School of Medicine for clinical pathology residency and hematopathology fellowship. Thereafter, she joined the faculty at Johns Hopkins, progressed through their academic ranks to Professor, and served as the pathology department's Deputy Director (Vice Chair) for Research and Director of the institution's Physician Scientist Training Program (PSTP). Dr. Burns's research focuses on high copy number genomic repeats and transposable elements, their contributions to human disease, and ways to leverage our understanding of their biology to diagnose and treat cancers.

    Her honors include the Richard Starr Ross Physician Scientist Award from Johns Hopkins University, a Career Award for Medical Scientists from the Burroughs Wellcome Fund, and membership in the American Society for Clinical Investigation, the Interurban Clinical Club, and the American Association for the Advancement of Science (AAAS). She has been invited to speak at at >130 events in 14 countries and given named lectures, including as the Scriver Family Visiting Professor at McGill University, the Daria Haust Lecturer at Queen’s University, the Thomas M. Wheeler Lecturer at Baylor College of Medicine, and the Peacock Memorial Lecturer at University of Texas Southwestern as well as Keynote addresses at the Cold Spring Harbor Laboratory and Cold Spring Harbor Asia
    Transposable Element meetings and the Gordon Research Conference on Cancer Genetics and Epigenetics.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematopathology, 2007 - 2008
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2004 - 2007
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2020 - 2026
  • MD State Medical License
    MD State Medical License 2008 - 2020
  • PA State Medical License
    PA State Medical License 2007 - 2008
  • Pathology - Clinical
    American Board of Pathology Pathology - Clinical
  • Hematopathology
    American Board of Pathology Hematopathology

Publications & Presentations

PubMed

Press Mentions

  • Dana-Farber Chair of Pathology, Dr. Kathleen Burns, Elected as Fellow of the American Association for the Advancement of Science
    Dana-Farber Chair of Pathology, Dr. Kathleen Burns, Elected as Fellow of the American Association for the Advancement of ScienceMarch 26th, 2026
  • A Potential Danger of CRISPR Gene Editing and Why Base Editing May Be Safer
    A Potential Danger of CRISPR Gene Editing and Why Base Editing May Be SaferJuly 14th, 2022
  • 'Jumping Genes' Unusually Active in Many Gastrointestinal Cancers, Studies Find
    'Jumping Genes' Unusually Active in Many Gastrointestinal Cancers, Studies FindAugust 17th, 2015

Grant Support

  • Defining the genomic and biologic impact of LINE-1 activity in fallopian tube epithelial cellsMASSACHUSETTS GENERAL HOSPITAL2025–2030
  • Immunological consequences of LINE-1 expression in cancerGEORGE WASHINGTON UNIVERSITY2024–2029
  • Single Molecule Detection of L1 Insertions and IntermediatesDANA-FARBER CANCER INST2023–2028
  • Consequences of retrotransposition on genome integrityDANA-FARBER CANCER INST2023–2028
  • Single Molecule Detection of L1 Insertions and IntermediatesDANA-FARBER CANCER INST2023–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: